New Coronavirus Drug Shows Promise in Animal Tests
Slated for human trials, EIDD-2801 could become the first pill for COVID-19
Slated for human trials, EIDD-2801 could become the first pill for COVID-19
Many new drugs trigger an immune reaction that cripples them—and the race is on to thwart the attack
Bacteria face trade-offs when optimizing traits involved in antibiotic resistance
By reprogramming DNA inside harmful microbes, biologists are turning them into patient-saving drugs
With no time to make treatments from scratch, researchers search for existing compounds that deflect harm
You have free articles left.
Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.